https://scholars.lib.ntu.edu.tw/handle/123456789/580046
標題: | Correction: Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinoma (British Journal of Cancer, (2019), 121, 3, (218-221), 10.1038/s41416-019-0506-6) | 作者: | Evans T.R.J. Kudo M. Finn R.S. Han K.-H. ANN-LII CHENG Ikeda M. Kraljevic S. Ren M. Dutcus C.E. Piscaglia F. Sung M.W. |
公開日期: | 2019 | 出版社: | Nature Publishing Group | 卷: | 121 | 期: | 7 | 來源出版物: | British Journal of Cancer | 摘要: | This article was originally published under a standard license to Publish, but has now been made available under a CC BY license. The PDF and HTML versions of the paper have been modified accordingly. An amendment to this paper has been published and can be accessed via a link at the top of the paper. ? 2019, The Author(s). |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85069924178&doi=10.1038%2fs41416-019-0534-2&partnerID=40&md5=73213eb7615a483299576b973fcb7eb3 https://scholars.lib.ntu.edu.tw/handle/123456789/580046 |
ISSN: | 0007-0920 | DOI: | 10.1038/s41416-019-0534-2 | SDG/關鍵字: | erratum |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。